The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

Christopher W. Helsen(McMaster University), Jonathan L. Bramson(McMaster University)
Nature Communications
July 30, 2018
Cited by 121


Related Papers